An international research team led by scientists at Queen Mary University of London has developed an innovative method to power wearable electronics using ambient moisture and simple, non-toxic materials commonly found in the kitchen.

Tumor cells exploit chemokine signaling to construct an immunosuppressive microenvironment that resists anti-tumor immune responses. A new review systematically maps the chemokine-receptor network in the tumor microenvironment and introduces a three-part “3D” targeting strategy: Decrease recruitment of suppressive cells (Tregs, MDSCs, TAMs), Develop effector T cell and NK cell function, and Dismantle physical and signaling barriers that exclude effectors from tumors. This framework ultimately provides a roadmap for precision combination immunotherapy to overcome immune evasion

As AI is being widely tested in medicine, scientists at the University of Auckland, Auckland City Hospital, and Matai Medical Research Institute in New Zealand have analyzed the current landscape of AI models for meningioma (a cancer of the brain’s soft cover) segmentation from MRI scans, and its path ahead. Their key finding is that advanced model architecture has considerably contributed to tumor detection sensitivity, rather than data characteristics, imaging modalities, or preprocessing.